https://www.frenelle.bio/news/frenelle-pharma-officially-launches%3A-ceo-missling-attends-jpm-2025-representing-frenelle%E2%80%99s-portfolio 2025-01-15 https://www.frenelle.bio/news/spinethera-featured-as-a-minnesota-company-working-on-alternatives-for-opioid-pain-medication 2025-01-10 https://www.frenelle.bio/news/spinethera-to-present-at-discovery-square-innovators-%26-investors-forum 2025-01-10 https://www.frenelle.bio/news/purdue-pharma-l.p.-enters-into-exclusive-option-agreement-to-acquire-spinethera%2C-inc.-and-its-non-opioid-product-in-development-for-epidural-steroid-injection-for-the-treatment-of-low-back-pain 2025-01-10 https://www.frenelle.bio/news/spinethera-receives-u.s.-patent-covering-sustained-release-injectable-corticosteroid%2C-sx600%2C-a-non-opioid-drug-in-development-for-low-back-pain 2025-01-10 https://www.frenelle.bio/news/spinethera-phase-1-2-clinical-sx600-non-opioid-epidural-injection-sciatica 2025-01-15 https://www.frenelle.bio/news/spinethera-announces-issuance-of-fourth-and-fifth-patents-covering-its-sustained-release-platform-technology 2025-01-10 https://www.frenelle.bio/news/spinethera-announces-addition-of-vice-president-of-global-clinical-operations-to-management-team 2025-01-10 https://www.frenelle.bio/news/spinethera-to-present-at-wvsipp-incube-meeting-in-conjunction-with-aspn-think-tank 2025-01-10 https://www.frenelle.bio/news/spinethera-awarded-%245-million-grant-from-department-of-defense 2025-01-10 https://www.frenelle.bio/news/doug-drysdale-and-dr.-shaheen-lakhan-join-spinethera-board 2025-01-10 https://www.frenelle.bio/news/spinethera-announces-results-for-sx600-from-its-salient-phase-2-sciatica-pain-clinical-trial-supporting-the-potential-for-best-in-class-therapy 2025-01-10 https://www.frenelle.bio/news/spinethera-announces-breakthrough-market-research-results-for-sx600-in-the-management-of-sciatica-pain 2025-01-10 https://www.frenelle.bio/news/spinethera-salient-clinical-trial-results-to-be-presented-at-upcoming-22nd-annual-asra-pain-medicine-meeting 2025-01-10 https://www.frenelle.bio/news/spinethera-celebrates-milestone-achievement-with-6th-patent-issued-by-the-us-patent-and-trademark-office 2025-01-10 https://www.frenelle.bio/news/promed-pharma-acquires-spinethera-manufacturing-capabilities-and-an-option-to-license-intellectual-property 2025-01-10 https://www.frenelle.bio/news/spinethera%2C-inc.-to-collaborate-with-mayo-clinic-to-advance-solutions-in-substance-abuse-disorder-treatment 2025-01-10 https://www.frenelle.bio/news/actym-therapeutics-expands-management-team-with-key-appointments-to-build-product-pipeline-and-advance-clinical-development-strategies 2025-01-10